Bausch Health Companies Inc. SEC filings BHC
Bausch Health Companies Inc. has 1,004 filings in SEC EDGAR's recent list, going back to May 4, 2016. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 19, 2026 |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 15, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 1, 2026 | Jun 26, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 26, 2026 | May 22, 2026 |
| 4 | Insider transaction | May 20, 2026 | May 19, 2026 |
| 3 | Initial insider ownership | May 20, 2026 | May 19, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2026 | May 19, 2026 |
| 144 | Notice of proposed sale | May 19, 2026 | — |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| ARS | Annual report to shareholders | Apr 8, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | May 19, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Feb 27, 2026 |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 2, 2026 | Feb 26, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 25, 2026 |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 10-K | Annual report | Feb 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jan 2, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 29, 2025 | Dec 26, 2025 |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Other events
|
Dec 9, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Nov 28, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 9, 2025 | Oct 7, 2025 |
| 4/A | Primary document | Oct 6, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Other events
|
Sep 11, 2025 | Sep 11, 2025 |
| SC TO-T/A | Filing | Sep 11, 2025 | — |
| 4 | Insider transaction | Sep 8, 2025 | Sep 5, 2025 |
| 144 | Notice of proposed sale | Sep 8, 2025 | — |
| DEF 14A | Proxy statement | Aug 27, 2025 | Oct 7, 2025 |
| SC TO-T/A | Filing | Aug 26, 2025 | — |
| 4 | Insider transaction | Aug 22, 2025 | Aug 21, 2025 |
| 144 | Notice of proposed sale | Aug 21, 2025 | — |
| 8-K |
Current report
Agreement ended, Officer or director change, Regulation FD disclosure
|
Aug 15, 2025 | Aug 14, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 15, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 14, 2025 |
| 3 | Initial insider ownership | Aug 14, 2025 | Aug 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 13, 2025 | Oct 7, 2025 |
| SC TO-T | Filing | Aug 12, 2025 | — |
| S-8 | Employee stock plan registration | Jul 31, 2025 | — |
| SC TO-C | Filing | Jul 31, 2025 | — |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| SC TO-C | Filing | Jul 30, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Jul 29, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Jul 29, 2025 | Jul 22, 2025 |
| SC TO-C | Filing | Jul 29, 2025 | — |
| SC TO-C | Filing | Jul 29, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 18, 2025 | Jul 17, 2025 |
| 4 | Insider transaction | Jul 16, 2025 | Jul 15, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 14, 2025 |
| 3 | Initial insider ownership | Jul 15, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 10, 2025 | Jul 10, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Other events
|
Jun 18, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 17, 2025 | Jun 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 17, 2025 | — |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Other events
|
Jun 10, 2025 | Jun 10, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 21, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 21, 2025 | — |
| 8-K |
Current report
Material agreement
|
May 21, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 16, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Officer or director change
|
May 15, 2025 | May 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2025 | Apr 30, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| CERT | Nyse certification | Apr 17, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Regulation FD disclosure
|
Apr 15, 2025 | Apr 14, 2025 |
| 8-A12B | Filing | Apr 15, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
Apr 9, 2025 | Apr 8, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 7, 2025 | — |
| ARS | Annual report to shareholders | Apr 2, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 2, 2025 | — |
| DEF 14A | Proxy statement | Apr 2, 2025 | May 13, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Other events
|
Mar 19, 2025 | Mar 19, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 3, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 28, 2025 | Feb 26, 2025 |
| 10-K | Annual report | Feb 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 19, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| 8-K |
Current report
Material agreement, New debt
|
Nov 1, 2024 | Nov 1, 2024 |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| SD | Specialized disclosure (conflict minerals) | Sep 20, 2024 | — |
| 4 | Insider transaction | Sep 9, 2024 | Sep 5, 2024 |
| 4 | Insider transaction | Sep 9, 2024 | Sep 5, 2024 |
| 144 | Notice of proposed sale | Sep 6, 2024 | — |
| 4 | Insider transaction | Sep 3, 2024 | Aug 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Aug 30, 2024 | — |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 3 | Initial insider ownership | Aug 20, 2024 | Aug 19, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 19, 2024 | — |
| S-8 | Employee stock plan registration | Aug 1, 2024 | — |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Jul 19, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 19, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 3 | Initial insider ownership | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4/A | Primary document | Jun 6, 2024 | Feb 29, 2024 |
| 4/A | Primary document | Jun 5, 2024 | Feb 29, 2024 |
| 4/A | Primary document | May 21, 2024 | May 17, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 17, 2024 |
| 4 | Insider transaction | May 21, 2024 | May 17, 2024 |
| 3 | Initial insider ownership | May 21, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 17, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 17, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 17, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BHC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NJ
- Headquarters
- Quebec, Quebec, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 885590
- Former names
- Valeant Pharmaceuticals International, Inc. (until Jul 3, 2018); BIOVAIL Corp (until Sep 27, 2010); BIOVAIL CORP INTERNATIONAL (until Apr 7, 2010); BIOVAIL CORPORATION INTERNATIONAL (until Jan 5, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.